PACIFIC-AMI

Objective
The purpose of this study is to try to find the best dose of the study drug to give to participants and to look at how well BAY 2433334 works in participants following a heart attack, as well as to learn if the study drug is safe for the participants and how it affects the body. This study is also done to learn how the study drug in this study moves into, through and out of the body. This is called “Pharmacokinetics (PK)."
Multicenter, randomized, placebo controlled, double-blind, parallel group, dose-finding Phase 2 study to evaluate the efficacy and safety of BAY 2433334 in patients following an acute myocardial infarction.

Research Study Categories

  • Adult Studies

Specialty

  • Cardiology
Contact
Cardiology Clinical Trials at 866-839-4128
or clinicaltrials@essentiahealth.org

Like most websites, we use cookies and other technologies to keep our website reliable, secure, and to better understand how our site is used. By using our site, you agree to our use of these tools. Learn more.